Timelines, Clock Stops, and What Silence Means

Part of Regulatory Affairs and the Jurisdiction Map: The European Union under CTR 536/2014.

About 5 minutes. Free, in your language, no account needed.

Why this matters

A regulatory timeline is not an estimate. It is a set of defined periods, with defined events that pause them and defined consequences when a party misses one.

Teams treat these as forecasts, which produces two failures. They plan as though the maximum period were the expected one, wasting weeks. Or they plan as though the minimum were reliable and discover that a single request for information moved the date by a month.

The professional skill is knowing which parts of the clock you control and which you do not, and being precise with the study team about the difference.

The structure of the period

The procedure runs in defined stages. There is a validation step in which the application is checked for completeness before assessment begins. There is an assessment period for Part I, led by the reporting member state with input from the other member states concerned. There is a parallel national assessment of Part II. And there is a notification of the decision.

The periods differ depending on what is being applied for. An initial application, the addition of a member state, and a substantial modification each have their own defined periods.

Two features of the structure matter more than the specific numbers.

Validation precedes assessment. An application that fails validation has not started its assessment clock. A team that counts from the submission date when the application sat in validation for two weeks will be two weeks wrong about every downstream date.

The clock stops for requests for information. When the authorities ask a question, the period pauses while the sponsor prepares its answer, and it resumes when the answer arrives. This is the single largest source of variance, and it is also the part the sponsor controls.

The part you control

Draw the line clearly, because it changes how you manage the study team's expectations.

Not in your control: the length of the defined assessment periods, the reporting member state's workload, whether questions are asked, and each member state's national Part II process.

Entirely in your control: whether the application validates first time, how long you take to answer a request for information, and whether your answer is complete enough to avoid a second question.

That last one is where experienced regulatory professionals earn their timelines. A question answered in four days with a complete response costs four days. The same question answered in three days with a partial response costs three days plus a second question plus another response period, often three weeks in total.

The instinct to answer fast is wrong. The right instinct is to answer completely, and to answer the question that was asked rather than the question you would have preferred.

Tacit approval, and why it is rare

Some regulatory systems provide that if the authority does not respond within a period, the application is deemed approved. This is genuinely unusual, and assuming it is a serious error.

The United States is the well known case: under its investigational new drug framework a sponsor may proceed thirty days after submission unless the agency imposes a clinical hold. Silence there means proceed.

In most of the world, and in the European framework, silence does not mean approval. It means the process is still running, or something has gone wrong with it, and the correct response is to find out which rather than to infer consent.

Where a deemed-approval mechanism does exist, it is conditioned. Establish the conditions before relying on it, and document the basis on which you concluded the period had run.

In practice

A study team asks the regulatory lead for the European start date, and wants a single date for the Gantt chart.

The honest answer has a shape rather than a point. Validation, then the Part I assessment period, then national Part II decisions, with the largest variance sitting in whether questions are asked and how quickly they are answered.

The lead gives three dates rather than one: an earliest date assuming clean validation and no questions, an expected date assuming one round of questions answered in a week, and a date beyond which the plan needs rebuilding. She also names the single lever that moves all three, which is the completeness of the response if questions come.

The study team can work with three dates. They cannot work with one date that turns out to be wrong, and they will not forgive a single date presented with false confidence.

What this looks like when it goes wrong

A sponsor receives a request for information and routes it to the study team, which routes it to a vendor, which takes three weeks to produce a figure.

The clock is stopped the whole time. Nobody is tracking it because the application is not technically overdue, and the regulatory system correctly shows the application as awaiting the sponsor.

Three weeks of the study timeline evaporate with no event to notice. There is no alarm, no missed deadline, and no report, because the sponsor is the party holding the clock. The study simply starts three weeks later than the plan, and the plan is revised to match rather than the delay being examined.

The countermeasure is to treat a stopped clock as an active deadline with an owner and a date, rather than as a pause in which nothing is due.

Key takeaways